Search

everythinglearnresearchcommunity

for

Search:↓

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Adding soybean oil to Nonomuraea dietziae increases production of a beneficial compound by improving metabolism and enzyme systems.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

A genetic marker linked to a type of hair loss was found in most patients studied.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Chromosomal differences affect how muscle cells respond to testosterone.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

CYP2B12 enzyme in skin cells converts arachidonic acid into specific bioactive lipids.

The dietary supplement helped increase hair growth in women with hair loss.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Researchers developed a method to identify and analyze cyclosporin compounds and their structures effectively.